Upgrade to SI Premium - Free Trial

Piper Jaffray Raises Price Target on Amgen (AMGN) to $200 Following 2Q EPS Beat

July 31, 2015 10:47 AM
Piper Jaffray reiterated an Overweight rating on Amgen (NASDAQ: AMGN), and raised the price target to $200.00 (from $192.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles